A prostate biopsy is a procedure to remove small samples of tissue from the prostate gland. It's a method to test for prostate cancer if a prostate-specific antigen (PSA) blood test or digital rectal ...

MRI does not reliably exclude clinically significant prostate cancer in about one quarter of patients receiving active surveillance, confirming that MRI is not a substitute for biopsy.

Local anesthetic transperineal (LATP) biopsy for prostate cancer detection is gaining in popularity due to concerns about infectious complications with transrectal ultrasound (TRUS) biopsy. LATP ...

Omitting systematic biopsy in men with elevated prostate-specific antigen (PSA) levels and negative MRI results, and performing only targeted biopsy of MRI-positive lesions, eliminated more than half ...

University Hospital in Newark — which is also the principal teaching hospital for Rutgers New Jersey Medical School — added the transperineal prostate biopsy procedure to its cancer-detection arsenal.

Men reveal struggles with prostate cancer screening - YOUR VIEWS : Our community has shared frustration over NHS barriers to ...

Jim, a 57-year-old Boston businessman, climbs up on an examining room table at Brigham and Women's Hospital for a procedure that's high on most men's list of dreads: a prostate biopsy. A doctor will ...

Screening for prostate cancer is burdened by a high rate of overdiagnosis. The most appropriate algorithm for population-based screening is unknown. We invited 37,887 men who were 50 to 60 years of ...

After skin cancer, prostate cancer is the most common cancer among American men, according to the American Cancer Society. Nearly 165,000 new cases of prostate cancer will be diagnosed in 2018, and ...

Prostate biopsy can miss up to 30% of clinically significant tumors, often because the biopsy procedure fails to sample the tumor, instead taking tissue from nearby nonmalignant stroma. The authors of ...